PepGen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PepGen and other ETFs, options, and stocks.

About PEPG

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. 

CEO
James Gregg McArthur
CEOJames Gregg McArthur
Employees
81
Employees81
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2018
Founded2018
Employees
81
Employees81

PEPG Key Statistics

Market cap
387.05M
Market cap387.05M
Price-Earnings ratio
-1.99
Price-Earnings ratio-1.99
Dividend yield
Dividend yield
Average volume
749.50K
Average volume749.50K
High today
$5.69
High today$5.69
Low today
$5.68
Low today$5.68
Open price
$5.43
Open price$5.43
Volume
3.31K
Volume3.31K
52 Week high
$7.80
52 Week high$7.80
52 Week low
$0.8801
52 Week low$0.8801

Stock Snapshot

PepGen(PEPG) stock is priced at $5.68, giving the company a market capitalization of 387.05M. It carries a P/E multiple of -1.99.

During the trading session on 2026-01-23, PepGen(PEPG) shares reached a daily high of $5.69 and a low of $5.68. At a current price of $5.68, the stock is 0.0% higher than the low and still -0.2% under the high.

Trading volume for PepGen(PEPG) stock has reached 3.31K, versus its average volume of 749.5K.

Over the past 52 weeks, PepGen(PEPG) stock has traded between a high of $7.80 and a low of $0.88.

Over the past 52 weeks, PepGen(PEPG) stock has traded between a high of $7.80 and a low of $0.88.

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
0%
Sell
16.7%

People also own

Based on the portfolios of people who own PEPG. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.